Host Defenses to Viruses: Lessons from Inborn Errors of Immunity.

EBV HSV SARS-CoV-2 genetic host immunity influenza susceptibility viruses

Journal

Medicina (Kaunas, Lithuania)
ISSN: 1648-9144
Titre abrégé: Medicina (Kaunas)
Pays: Switzerland
ID NLM: 9425208

Informations de publication

Date de publication:
07 Feb 2022
Historique:
received: 12 12 2021
revised: 27 01 2022
accepted: 29 01 2022
entrez: 25 2 2022
pubmed: 26 2 2022
medline: 1 3 2022
Statut: epublish

Résumé

The constant battle between viruses and their hosts leads to their reciprocal evolution. Viruses regularly develop survival strategies against host immunity, while their ability to replicate and disseminate is countered by the antiviral defense mechanisms that host mount. Although most viral infections are generally controlled by the host's immune system, some viruses do cause overt damage to the host. The outcome can vary widely depending on the properties of the infecting virus and the circumstances of infection but also depends on several factors controlled by the host, including host genetic susceptibility to viral infections. In this narrative review, we provide a brief overview of host immunity to viruses and immune-evasion strategies developed by viruses. Moreover, we focus on inborn errors of immunity, these being considered a model for studying host response mechanisms to viruses. We finally report exemplary inborn errors of both the innate and adaptive immune systems that highlight the role of proteins involved in the control of viral infections.

Identifiants

pubmed: 35208572
pii: medicina58020248
doi: 10.3390/medicina58020248
pmc: PMC8879264
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Science. 2020 Oct 23;370(6515):
pubmed: 32972995
Blood. 2020 Feb 27;135(9):610-619
pubmed: 31942628
Cell. 2006 Feb 24;124(4):767-82
pubmed: 16497587
J Allergy Clin Immunol. 2018 Jan;141(1):59-68.e4
pubmed: 28669558
J Allergy Clin Immunol. 2017 Apr;139(4):1302-1310.e4
pubmed: 27658761
Cancers (Basel). 2021 Sep 23;13(19):
pubmed: 34638238
Nature. 2020 Aug;584(7821):430-436
pubmed: 32640463
Front Immunol. 2019 Aug 13;10:1908
pubmed: 31456805
J Allergy Clin Immunol. 2019 Feb;143(2):507-527
pubmed: 30075154
Nat Med. 2004 Dec;10(12 Suppl):S88-97
pubmed: 15577937
J Infect Dis. 2020 May 11;221(11):1762-1769
pubmed: 32227123
J Allergy Clin Immunol. 2018 Aug;142(2):605-617.e7
pubmed: 29330011
J Allergy Clin Immunol. 2011 Jun;127(6):1329-41.e2; quiz 1342-3
pubmed: 21514636
Front Immunol. 2018 Jan 16;8:2005
pubmed: 29387064
PLoS One. 2021 Aug 30;16(8):e0249484
pubmed: 34460826
Viruses. 2018 Jan 20;10(1):
pubmed: 29361691
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
J Allergy Clin Immunol. 2019 Jan;143(1):276-291.e6
pubmed: 29800648
Sci Immunol. 2020 Jul 10;5(49):
pubmed: 32651211
Blood. 2020 Feb 27;135(9):644-655
pubmed: 31942615
Front Immunol. 2021 Aug 30;12:731643
pubmed: 34527001
Immunol Rev. 2019 Sep;291(1):174-189
pubmed: 31402499
Front Oncol. 2019 Aug 06;9:713
pubmed: 31448229
Immunity. 2012 Nov 16;37(5):771-83
pubmed: 23159225
Proc Biol Sci. 2015 Dec 22;282(1821):20143085
pubmed: 26702035
Pediatr Allergy Immunol. 2017 Aug;28(5):478-484
pubmed: 28512785
J Clin Invest. 2015 Nov 2;125(11):4135-48
pubmed: 26457731
Ann N Y Acad Sci. 2010 Dec;1214:18-33
pubmed: 21091717
Trends Ecol Evol. 2012 Nov;27(11):627-36
pubmed: 22901901
Science. 2020 Oct 23;370(6515):
pubmed: 32972996
Infect Immun. 2007 Apr;75(4):1545-55
pubmed: 17283094
Pflugers Arch. 2012 Jan;463(1):121-37
pubmed: 22071480
Hum Genet. 2020 Jun;139(6-7):941-948
pubmed: 32025908
Front Endocrinol (Lausanne). 2020 Sep 30;11:579401
pubmed: 33101211
Front Immunol. 2017 Nov 24;8:1658
pubmed: 29225606
N Engl J Med. 2020 May 28;382(22):2081-2090
pubmed: 32329971
Curr Opin Virol. 2021 Feb;46:1-8
pubmed: 32771660
PLoS Med. 2006 Jul;3(7):e292
pubmed: 16756392
Proc Natl Acad Sci U S A. 2015 Dec 22;112(51):E7128-37
pubmed: 26621750
Glob Health Promot. 2021 Jun 24;:17579759211018417
pubmed: 34165015
Proc Natl Acad Sci U S A. 2004 Oct 5;101 Suppl 2:14560-6
pubmed: 15297608
Nat Med. 2019 Dec;25(12):1873-1884
pubmed: 31806906
Front Immunol. 2018 Feb 23;9:237
pubmed: 29599765

Auteurs

Lucia Leonardi (L)

Maternal, Infantile and Urological Sciences Department, Sapienza University of Rome, 00161 Rome, Italy.

Beatrice Rivalta (B)

Research Unit of Primary Immunodeficiencies, Academic Department of Pediatrics, Immune and Infectious Diseases Division, Bambino Gesuù Children's Hospital, IRCCS, 00165 Rome, Italy.
Department of Systems Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.

Fabrizio Leone (F)

Maternal, Infantile and Urological Sciences Department, Sapienza University of Rome, 00161 Rome, Italy.

Caterina Cancrini (C)

Research Unit of Primary Immunodeficiencies, Academic Department of Pediatrics, Immune and Infectious Diseases Division, Bambino Gesuù Children's Hospital, IRCCS, 00165 Rome, Italy.
Department of Systems Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.

Carlo Caffarelli (C)

Pediatric Clinic, Department of Medicine and Surgery, University of Parma, 43121 Parma, Italy.

Gian Luigi Marseglia (GL)

Pediatric Clinic, Fondazione IRCSS Policlinico San Matteo, 27100 Pavia, Italy.

Fabio Cardinale (F)

Department of Pediatrics, University of Bari, Azienda Ospedaliera-Universitaria "Consorziale-Policlinico", Ospedale Pediatrico Giovanni XXIII, 70123 Bari, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH